Market revenue in 2023 | USD 400.1 million |
Market revenue in 2030 | USD 1,007.8 million |
Growth rate | 14.1% (CAGR from 2023 to 2030) |
Largest segment | Cytokines & growth factors |
Fastest growing segment | Cytokines & Growth Factors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 22.47% in 2023. Horizon Databook has segmented the U.S. research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. research-grade proteins market has emerged as a growing and dynamic sector within the life sciences industry. This growth can be attributed to the expansion of biotechnology, which creates the demand for highly purified and well-characterized proteins for research purposes.
Thus, the rising demand for research-grade proteins is expected to propel during the forecast period. The market is further fueled by the pharmaceutical & biopharmaceutical sectors, where protein-based therapies and drug development continue to gain prominence.
Moreover, advancements in proteomics & genomics research have created a demand for precisely engineered proteins for experimentation and analysis. For instance, in August 2023, Phase Genomics was awarded a sum of USD 2.5 million to develop a diagnostic score centered on genome-wide chromosomal abnormalities for specific cancer types.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into U.S. research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account